| scholarly article | Q13442814 |
| P2093 | author name string | G. H. Cohen | |
| R. J. Eisenberg | |||
| C. Hydrean-Stern | |||
| Hydrean-Stern C | |||
| M. Katze | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Control of Protein Synthesis in Herpesvirus-infected Cells: Analysis of the Polypeptides Induced by Wild Type and Sixteen Temperature-sensitive Mutants of HSV strain 17 | Q28258056 | ||
| A Film Detection Method for Tritium-Labelled Proteins and Nucleic Acids in Polyacrylamide Gels | Q29547782 | ||
| Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins | Q35051537 | ||
| Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion | Q36503262 | ||
| Detection of a virus-specific antigen on the surface of herpes simplex virus-transformed cells | Q36532597 | ||
| Inhibition of herpes simplex virus type 2 replication by thymidine | Q36561413 | ||
| Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains | Q36564133 | ||
| Proteins specified by herpes simplex virus. XIII. Glycosylation of viral polypeptides | Q36568465 | ||
| Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. | Q36591131 | ||
| Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells | Q37500512 | ||
| Effects of 2-deoxyglucose, glucosamine, and mannose on cell fusion and the glycoproteins of herpes simplex virus | Q37502765 | ||
| Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide | Q39953380 | ||
| Polyacrylamide gel electrophoretic analysis of herpes simplex virus type 1 immunoprecipitates obtained by quantitative immunoelectrophoresis in antibody-containing agarose gel | Q39976681 | ||
| Purification of Equine Herpesvirus Type 1 | Q39985924 | ||
| Type C virus activation in “nontransformed” mouse cells by UV-irradiated herpes simplex virus | Q40054071 | ||
| Some Structural Antigens of Herpes Simplex Virus Type 1 | Q40184617 | ||
| Separation of Herpes simplex virus-induced antigens by Concanavalin A affinity chromatography | Q40637643 | ||
| Envelope glycoproteins of Rauscher murine leukemia virus: isolation and chemical characterization | Q41227481 | ||
| Application of a microtechnique to viral serological investigations. | Q44916398 | ||
| The relationship of the herpes simplex haemadsorption phenomenon to the virus growth cycle | Q44956579 | ||
| Studies of the determinant antigens of viable cells. I. A method, and its application in tissue culture studies, for enumeration of killed cells, based on the failure of virus multiplication following injury by cytotoxic antibody and complement | Q45711293 | ||
| Herpes simplex virus-specific polypeptides studied by polyacrylamide gel electrophoresis of immune precipitates | Q45818605 | ||
| Effects of 2-deoxy-D-glucose on herpes simplex virus replication | Q45819749 | ||
| Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody | Q45826506 | ||
| Immunological and biochemical characterization of polypeptides induced by herpes simplex virus types 1 and 2 | Q66707021 | ||
| Morphological components of herpesvirus. I. Intercapsomeric fibrils and the geometry of the capsid | Q68710508 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| microbiology | Q7193 | ||
| P304 | page(s) | 172-181 | |
| P577 | publication date | 1978-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein | |
| Type-Common CP-1 Antigen of Herpes Simplex Virus Is Associated with a 59,000-Molecular-Weight Envelope Glycoprotein | |||
| P478 | volume | 27 |
| Q36868657 | A multigene family encodes the human cytomegalovirus glycoprotein complex gcII (gp47-52 complex). |
| Q36797418 | Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein |
| Q33921988 | Alterations in Glycoprotein gB Specified by Mutants and Their Partial Revertants in Herpes Simplex Virus Type 1 and Relationship to Other Mutant Phenotypes |
| Q36911259 | Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2 |
| Q45798863 | An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D |
| Q36872389 | Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants |
| Q36930264 | Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies |
| Q36444916 | Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera |
| Q45796357 | Bacterial Synthesis of Herpes Simplex Virus Types 1 and 2 Glycoprotein D Antigens |
| Q33910508 | Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells |
| Q36907968 | Characterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein C |
| Q36797424 | Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides |
| Q35672127 | Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes |
| Q34092845 | Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge |
| Q33923748 | Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2 |
| Q35868099 | Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry |
| Q36793428 | Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. |
| Q44757003 | DNA Sequence Analysis of the Type-Common Glycoprotein-D Genes of Herpes Simplex Virus Types 1 and 2 |
| Q45796837 | DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene |
| Q36930169 | Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C |
| Q45797714 | Detection of Antibodies to Herpes Simplex Virus with a Continuous Cell Line Expressing Cloned Glycoprotein D |
| Q37110812 | Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody |
| Q35469980 | Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells |
| Q27486188 | Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2 |
| Q36937956 | Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. |
| Q33917728 | Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production |
| Q45878873 | Effects ofin VivoDepletion of Immunocyte Populations on Herpes Simplex Virus Glycoprotein D Vaccine-Induced Resistance to HSV2 Challenge |
| Q45850884 | Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2. |
| Q36920514 | Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells |
| Q45800397 | Evaluation of solubilized herpes simplex virus membrane antigens in diffusion in gel-enzyme-linked immunosorbent assay (DIG-ELISA) |
| Q45806871 | Expression of Herpes simplex virus type 1 glycoprotein C antigens in Escherichia coli |
| Q36868575 | Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells |
| Q36827612 | Fine mapping of antigenic site II of herpes simplex virus glycoprotein D |
| Q36895541 | Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D |
| Q36931969 | Glycopeptides of the Type-Common Glycoprotein gD of Herpes Simplex Virus Types 1 and 2 |
| Q45796492 | Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells |
| Q37099580 | Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. |
| Q72924823 | Glycoprotein processing in mutants of HSV-1 that induce cell fusion |
| Q36925805 | Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies |
| Q45799667 | Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression inEscherichia coli |
| Q35842415 | Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. |
| Q40131587 | Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infectivity |
| Q33784923 | Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo |
| Q36906946 | Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants |
| Q36940439 | Herpesvirus glycoprotein synthesis and insertion into plasma membranes |
| Q37688772 | Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D. |
| Q40616009 | Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections |
| Q35852869 | Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. |
| Q40098791 | Immunochemistry of Herpes Simplex Virus Glycoproteins |
| Q36444869 | Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus |
| Q45840510 | Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coli |
| Q36442697 | Immunological reactivity of herpes simplex virus 1 and 2 polypeptides electrophoretically separated and transferred to diazobenzyloxymethyl paper. |
| Q45803456 | Immunoprecipitation of polypeptides from hamster embryo cells transformed by herpes simplex virus type 2 |
| Q36832178 | Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D. |
| Q42823560 | Inhibition of glycosylation of herpes simplex virus glycoproteins: Identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane |
| Q39700044 | Inner tegument protein pUL37 of herpes simplex virus type 1 is involved in directing capsids to the trans-Golgi network for envelopment |
| Q36909419 | Insertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D |
| Q36328865 | Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins. |
| Q36892425 | Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50 |
| Q36910738 | Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody |
| Q36883752 | Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting |
| Q36898378 | Localization of epitopes of herpes simplex virus type 1 glycoprotein D |
| Q36912992 | Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes |
| Q36912927 | Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein |
| Q36495307 | Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity |
| Q36495340 | Membrane proteins specified by herpes simplex viruses. IV. Conformation of the virion glycoprotein designated VP7(B2) |
| Q37601627 | Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein |
| Q36493493 | Molecular Genetics of Herpes Simplex Virus II. Mapping of the Major Viral Glycoproteins and of the Genetic Loci Specifying the Social Behavior of Infected Cells |
| Q36431330 | Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. |
| Q35242073 | Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2 |
| Q36887606 | Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses |
| Q36987928 | Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement |
| Q36829924 | Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration |
| Q36919500 | Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration |
| Q30441453 | Nuclear egress and envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+) |
| Q36903456 | Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions |
| Q35977563 | Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2 |
| Q33926080 | Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1. |
| Q36939761 | Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody |
| Q40612792 | Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. |
| Q41888076 | Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells |
| Q33934324 | Soluble glycoprotein D blocks herpes simplex virus type 1 infection of rat eyes |
| Q36903438 | Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. |
| Q36501558 | Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1 |
| Q33919700 | Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2 |
| Q36698675 | Structural basis of C3b binding by glycoprotein C of herpes simplex virus |
| Q36909711 | Synthesis and processing of glycoprotein D of herpes simplex virus types 1 and 2 in an in vitro system |
| Q36507398 | Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1. |
| Q36868606 | The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D |
| Q45803938 | The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus |
| Q41179042 | Type-common and type-specific monoclonal antibody to herpes simplex virus type 1 |
| Q36335255 | Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection |
| Q36429254 | Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease |
| Q36330561 | Virus-specific antibodies in sera from patients with genital herpes simplex virus infection |
| Q40127125 | “The herpesvirus hypothesis”—Are Koch's postulates satisfied? |
Search more.